Study Finds Serotonin Plays a Role in Development of Mammary Glands
The development of mammary glands is controlled primarily by endocrine hormones. A study led by Nelson Horseman, PhD, professor and interim chair of the Department of Molecular and Cellular Physiology at the
, shows that serotonin (a brain neurotransmitter) also plays a role in mammary gland development. Findings from this study appear in the Feb. 10 issue of
Developmental Cell
in an article titled "Serotonin Regulates Mammary Gland Development via an Autocrine Paracrine Loop."
"It was a complete surprise when we found that serotonin, a chemical best known for its involvement in mood regulation, plays an important role in controlling the secretion of milk in the mammary glands," said Dr. Horseman.
Serotonin, along with other regulatory hormones such as dopamine and adrenaline, is classified as a biogenic monoamine. Until now, this molecule has not been associated with the development of mammary glands. Dr. Horseman's group found that mammary glands stimulated by prolactin express genes necessary for the biosynthesis of serotonin.
Findings from this study may suggest that drugs that alter serotonin synthesis or activity could have effects on milk production, milk quality, or breast cancer.
Co-authors from UC include: Manabu Matsuda, PhD, former postdoctoral fellow; Tatsuhiko Imaoka, PhD, former graduate student; Archie J. Vomachka, PhD, visiting professor from Arcadia University in Pennsylvania; Gary A. Gudelsky, PhD, professor in the UC College of Pharmacy; Zhaoyuan Hou, PhD, former graduate student; Meenakshi Mistry, research associate in the Department of Molecular and Cellular Physiology; Jason P. Bailey, graduate student in the Department of Molecular and Cellular Physiology; and Kathryn M. Nieport, research assistant in the Department of Molecular and Cellular Physiology.
View the entire article online at
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.